20035. SÍNDROME DE BING-NEEL, COMPLICACIÓN NEUROLÓGICA DE LA MACROGLOBULINEMIA DE WALDENSTRÖM

20035. SÍNDROME DE BING-NEEL, COMPLICACIÓN NEUROLÓGICA DE LA MACROGLOBULINEMIA DE WALDENSTRÖM

Saved in:

Bibliographic Details
Main Authors:	N. Peláez Viña, D. Dunlop Bórquez
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Neurology Perspectives
Online Access:	http://www.sciencedirect.com/science/article/pii/S266704962401055X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bing and Neel Syndrome
by: S. Jennane, et al.
Published: (2012-01-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

20032. CEGUERA CORTICAL REVERSIBLE COMO COMPLICACIÓN TARDÍA A RADIOTERAPIA CEREBRAL
by: N. Peláez Viña, et al.
Published: (2024-11-01)

CNS Vasculitis Associated with Waldenström Macroglobulinemia
by: Tanawan Riangwiwat, et al.
Published: (2016-01-01)

Focal Segmental Glomerulosclerosis in Waldenström’s Macroglobulinemia
by: Akshee Batra, et al.
Published: (2020-01-01)

20034. SÍNDROME RÍGIDO-ACINÉTICO SECUNDARIO A INTOXICACIÓN POR MONÓXIDO DE CARBONO CON AFECTACIÓN BIPALIDAL
by: N. Peláez Viña, et al.
Published: (2024-11-01)

Bing–Neel Syndrome: An Unknown GCA Mimicker
by: Arifa Javed, et al.
Published: (2024-01-01)

20630. UTILIDAD DEL DIAGNÓSTICO MOLECULAR EN EL SÍNDROME DE BING-NEEL. A PROPÓSITO DE UN CASO
by: A. Simarro Díaz, et al.
Published: (2024-11-01)

Waldenström Macroglobulinemia and Cerebral Venous Thrombosis: From Diagnosis to Complication
by: Paulo Zoé Costa, et al.
Published: (2019-01-01)

Systemic Amyloidosis and Cardiac Autonomic Neuropathy Associated with Waldenstrom’s Macroglobulinemia
by: Aasems Jacob, et al.
Published: (2017-01-01)

A Diagnostic Dilemma: Waldenström's Macroglobulinemia/Plasma Cell Leukemia
by: Bhawna Sethi, et al.
Published: (2012-01-01)

BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE
by: Marzia Varettoni, et al.
Published: (2017-10-01)

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib
by: Daniel S. O’Neil, et al.
Published: (2018-01-01)

20536. COMPLICACIONES NEUROLÓGICAS PARENQUIMATOSAS EN LA ENFERMEDAD DE BEHÇET
by: E. Estrada Palma, et al.
Published: (2024-11-01)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024-12-01)

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature
by: Ryan Nipp, et al.
Published: (2014-01-01)

HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
by: Mark R. Wallace
Published: (2020-01-01)

As a Cause of Fever Unknown Origin, Waldenstrom's Macroglobulinemia: a Case Report
by: mehmet ozen, et al.
Published: (2014-08-01)

Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach?
by: Eirini Solia, et al.
Published: (2024-12-01)

Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis
by: Michael J. Schatz, et al.
Published: (2021-01-01)

Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature
by: Riccardo Paggi, et al.
Published: (2023-04-01)

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment
by: Karima Amaador, et al.
Published: (2023-02-01)

20294. COMPLICACIONES NEUROLÓGICAS DE LAS ENDOCARDITIS INFECCIOSAS A LO LARGO DE 20 AÑOS
by: B. Martínez García, et al.
Published: (2024-11-01)

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01)

Waldenstrom’s Macroglobulinemia: A Report of Two Cases, One with Severe Retinopathy and One with Renal Failure
by: Naoko Kudo, et al.
Published: (2017-01-01)

Complicaciones neurológicas como motivo de ingreso en una Unidad de Cuidados Intensivos Oncológicos
by: Ariel Sosa-Remón, et al.
Published: (2023-12-01)

Manifestações neurológicas da Síndrome de Ogden: relato de caso
by: Rui Carlos Silva Júnior, et al.
Published: (2024-09-01)

Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
by: Maroun Bou Zerdan, et al.
Published: (2022-01-01)

Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity
by: Vaishali Bhardwaj, et al.
Published: (2024-12-01)

20976. MANIFESTACIONES NEUROLÓGICAS DEL SÍNDROME ANTIFOSFOLÍPIDO: UNA SERIE DE CASOS
by: C. Moreno Delicado, et al.
Published: (2024-11-01)

21149. AFECTACIÓN NEUROLÓGICA EN SÍNDROME DE SJÖGREN: A PROPÓSITO DE UN CASO
by: J. Serrano Sanchis, et al.
Published: (2024-11-01)

Mismatches in optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Sunny Chi Lik Au
Published: (2024-12-01)

CORRIGENDUM: Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Gilda Cennamo, et al.
Published: (2024-12-01)

Bing-Neel Syndrome Case Report: A Previously Undocumented IgG Variant with MRI, PET/CT, and PET/MRI Imaging
by: Daniel Halperin, et al.
Published: (2016-01-01)

21271. COMPLICACIONES NEUROLÓGICAS MÁS ALLÁ DE ICANS EN PACIENTES CON MIELOMA MÚLTIPLE TRATADOS CON TERAPIA CÉLULAS T EFECTORAS
by: C. Pérez Prol, et al.
Published: (2024-11-01)

Hepatitis viral aguda tipo A colestásica con manifestaciones extrahepáticas y complicaciones neurológicas poco frecuentes
by: Félix Báez Sarria, et al.
Published: (2024-04-01)

WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS
by: Michele Bibas, et al.
Published: (2024-06-01)

Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia
by: D. Kazmierski, et al.
Published: (2017-01-01)

21525. SÍNDROME DE TAPIA COMO COMPLICACIÓN POSQUIRÚRGICA INFRECUENTE TRAS INTUBACIÓN OROTRAQUEAL
by: P. Gutiérrez Bedia, et al.
Published: (2024-11-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)